This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of a Case

FRANCIS X. SCHLOEDER, M.D.

Arch Dermatol. 1961;84(4):601-602.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Amodiaquine (Camoquin) is chiefly used as an antimalarial, but has found recent favor in the treatment of chronic lupus erythematosus,¹ various photosensitive skin disorders,² and rheumatoid arthritis.³ Toxic reactions include gastrointestinal disturbances, and agranulocytosis has been reported not infrequently.⁴

In January, 1958, Bleil reported an unusual toxic manifestation characterized by yellow pigmentation, corneal edema, lethargy, anorexia, and amenorrhea.⁵ This is the only report of this type of reaction to this drug in the literature to date. We have recently observed a patient under treatment with amodiaquine for a nonspecific photosensitive skin reaction, who developed a very similar reaction, including pigmentation, muscle weakness, and myalgias, corneal edema, anorexia, and lethargy with muscle degeneration.

Report of Case

A 33-year-old white male had suffered from a photosensitive skin reaction for the past 7 years. Three years ago, this became worse and chloroquine therapy was instituted. This was not . . . [Full Text PDF of this Article]

Author Affiliations
BALBOA HEIGHTS CANAL ZONE

Resident, Department of Internal Medicine, Gorgas Hospital.

Footnotes
Submitted for publication April 24, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?